Clever Leaves Receives Largest 2021 Production Quotas from the Colombian Government Clever Leaves’ quota represents 50% of the total quota for Colombia and approximately 18% of the world’s legal production quota of medical cannabis
March 02, 2021 08:00 ET | Source: Clever Leaves Clever Leaves
NEW YORK, March 02, 2021 (GLOBE NEWSWIRE)
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced that the Colombian Technical Quotas Group ( TQG ) authorized Clever Leaves’ Colombian operations to manufacture up to approximately 59,000 kilograms of cannabis into dried flower derivatives. According to the International Narcotics Control Board’s publicly disclosed data, Clever Leaves’ total allocation represents 50% of Colombia’s total quota and approximately 18% of the world’s legal
One of those publicly traded cannabis companies, Clever Leaves Holdings, has seen its share prices double since the year began, but that doesn t necessarily change the business plans of the vertically integrated cannabis producer, according to CEO Kyle Detwiler. To learn more about how the recent investing frenzy will affect the pot industry, we caught up with Detwiler when cannabis stocks were still trading strongly in mid-February.
Westword: For someone who doesn t follow the stock market, how would you explain the recent surge in several cannabis stocks over the last month, and what s happened since?
Kyle Detwiler: Investors are starting to see positive regulatory developments, which will accelerate growth. Joe Biden is in the White House, Senate Majority Leader Chuck Schumer is talking about policy changes, and the United Nations has [reclassified cannabis].
Clever Leaves Appoints Hank Hague As CFO
Clever Leaves Holdings Inc. (NASDAQ:CLVR) has tapped Hank Hague to oversee its financial department on the heels of being added to the Cannabis ETF (NYSE:THCX), which trades on the New York Stock Exchange.
He led finances for several public and private companies within the pharmaceutical, biomedical, and cannabis industries during his career.
Previously, Hague, who replaces Amit Pandey, served as CFO of Abacus Health Products, Inc.
Kyle Detwiler, CEO of the New York cannabis company, said Monday they are “thrilled to welcome” Hague.
“Hank has an impressive corporate background, and he has demonstrated exceptional financial and strategic leadership in his previous roles,” Detwiler added.
Clever Leaves Strengthens Leadership Team and Appoints Hank Hague as Chief Financial Officer
Nachrichtenquelle: globenewswire | 22.02.2021, 14:00 | 130 | 0 NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the appointment of Hank Hague as its new Chief Financial Officer, effective immediately. Mr. Hague joins Clever Leaves with extensive experience in providing financial leadership to various public and private entities in the pharmaceutical, biomedical, and cannabis industries. Most recently, Mr. Hague served as CEO at Aidance Scientific, an FDA-registered manufacturer of branded and private label OTC topical medications. Prior to this r
Clever Leaves Added to NYSE-Listed Cannabis ETF THCX | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.